Novabay Pharmaceuticals Announces Preliminary Net Revenue For The Second Quarter Of 2024 Of $2.4M Versus Consensus Of $3.15M And For The First Half Of 2024 Of $5M, Primarily Derived From The Company's Eyecare Products
Novabay Pharmaceuticals Announces Preliminary Net Revenue For The Second Quarter Of 2024 Of $2.4M Versus Consensus Of $3.15M And For The First Half Of 2024 Of $5M, Primarily Derived From The Company's Eyecare Products
Novabay Pharmaceuticals宣布2024年第二季度初步净营业收入为240万美元，低于市场预期的315万美元，并且2024年上半年营业收入为500万美元，主要来自公司的眼科产品。
Net revenue from the Company's eyecare products increased by 9% for both the second quarter and the first half of 2024 over the corresponding periods in 2023. NovaBay also expects 2024 net revenue from the Company's eyecare products to be approximately $10 million.
该公司眼科产品的净营业收入在2024年第二季度和上半年相比于2023年同期增长了9%。NovaBay还预计2024年该公司眼科产品的净营业收入约为1000万美元。
资讯热榜
更新时间